Stay updated on Daratumumab in Combo with Lenalidomide & Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Combo with Lenalidomide & Dexamethasone Clinical Trial page.

Latest updates to the Daratumumab in Combo with Lenalidomide & Dexamethasone Clinical Trial page
- Check7 days agoChange DetectedFebruary 2026 updates appear as timestamp changes to study record dates and status, with minor edits to non-core items; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check14 days agoChange DetectedAdded topic labels 'Multiple myeloma' and related topics including 'MedlinePlus Genetics' and updated the site revision to v3.4.2. The notice about government funding status (and the older v3.4.1 revision) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and a revision (v3.4.1); removed the related topics 'Multiple Myeloma' and 'MedlinePlus Genetics' from the topics list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedMinor UI/metadata updates: glossary labeling, QC timestamps (Last Update Submitted that Met QC Criteria, Last Update Posted), and revision notes (Revision: v3.4.0) replacing older items (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4). These changes do not affect study content, eligibility criteria, outcomes, or user actions.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows related topics: Multiple myeloma and MedlinePlus Genetics under related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedAdministrative site updates were applied (revision v3.3.4) with minor topic adjustments; there are no changes to the study details, eligibility criteria, or locations.SummaryDifference0.3%

Stay in the know with updates to Daratumumab in Combo with Lenalidomide & Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Combo with Lenalidomide & Dexamethasone Clinical Trial page.